(Q70445840)
Statements
Suppression of testicular steroidogenesis by the GnRH agonistic analogue Buserelin (HOE-766) in patients with prostatic cancer: studies in relation to dose and route of administration (English)
G Tolis
N Faure
M Koutsilieris
A Lemay
S Klioze
A Yakabow